6533b883fe1ef96bd12dbc1a

RESEARCH PRODUCT

Addressing HCV Elimination Barriers in Italy: Health Care Resource Utilization and Cost Impact Using 8 Weeks’ Glecaprevir/Pibrentasvir Therapy

Adis Journals On Behalf OfMassimo AndreoniGiovanni Di PerriMarcello PersicoAndrea MarcellusiOlivier EthgenYuri Sanchez GonzalezMark BondinZhenzhen ZhangAntonella De MichinaRocco Cosimo Damiano MerollaAntonio Craxì

subject

description

Article full text The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2021.

https://dx.doi.org/10.6084/m9.figshare.13655654.v1